morphiceptin has been researched along with Adenocarcinoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fichna, J; Janecka, A; Mirowski, M; Wiercioch, R | 1 |
Balcerczak, E; Birnbaum, G; Byszewska, E; Byzia, S; Garnuszek, P; Janecka, A; Mirowski, M; Wiercioch, R; Wierzbicki, R | 1 |
2 other study(ies) available for morphiceptin and Adenocarcinoma
Article | Year |
---|---|
Synthesis of novel morphiceptin analogues modified in position 3 and their binding to mu-opioid receptors in experimental mammary adenocarcinoma.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line, Tumor; Endorphins; Iodine Radioisotopes; Ligands; Mammary Neoplasms, Experimental; Membrane Proteins; Mice; Molecular Weight; Protein Binding; Protein Conformation; Receptors, Opioid, mu; Stereoisomerism; Structure-Activity Relationship | 2003 |
Uptake of radiolabeled morphiceptin and its analogs by experimental mammary adenocarcinoma: in vitro and in vivo studies.
Topics: Adenocarcinoma; Animals; Endorphins; Female; Iodine Radioisotopes; Mammary Neoplasms, Experimental; Metabolic Clearance Rate; Mice; Mice, Inbred C3H; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Opioid, mu; Tissue Distribution | 2004 |